Aberrant transforming growth factor beta1-angiotensin II crosstalk in chronic obstructive pulmonary disease parenchymal fibroblasts

Aberrant transforming growth factor beta1-angiotensin II crosstalk in chronic obstructive pulmonary disease parenchymal fibroblasts

Show other versions (1)

Rationale: The airflow limitation in Chronic Obstructive Pulmonary Disease (COPD) is caused by small airways obstruction and/or obliteration and emphysematous destruction of parenchymal tissue. Our group previously characterized a gene expression signature for emphysema that included members of the...

Full description

Bibliographic Details
Main Author:	Wee, Tracee
Language:	English
Published:	University of British Columbia 2014
Online Access:	http://hdl.handle.net/2429/46418

Similar Items

Aberrant transforming growth factor beta1-angiotensin II crosstalk in chronic obstructive pulmonary disease parenchymal fibroblasts
by: Wee, Tracee
Published: (2014)

An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.
by: Sandra Grumelli, et al.
Published: (2004-10-01)

Crosstalk between transforming growth factor-beta and Wnt signalling pathways in dermal fibroblasts
by: Gillespie, Justin
Published: (2015)

Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease
by: Lijiao Zhang, et al.
Published: (2021-09-01)

Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease
by: Tan Wan, et al.
Published: (2010-12-01)

Oxidative modification of albumin in the parenchymal lung tissue of current smokers with chronic obstructive pulmonary disease
by: Hackett, Tillie-Louise, et al.
Published: (2010)

Altered DNA methylation is associated with aberrant gene expression in parenchymal but not airway fibroblasts isolated from individuals with COPD
by: Rachel L. Clifford, et al.
Published: (2018-03-01)

The renin-angiotensin system enzymes in chronic obstructive pulmonary disease
by: Rajaram, Jessica
Published: (2016)

Fibroblast growth factor-23 and hypophosphatemia in chronic obstructive pulmonary disease patients
by: Elsammak Mohamed Y., et al.
Published: (2012-01-01)

R-Smad 2 activation in infarcted rat heart : crosstalk between angiotensin II and TGF-[beta]1
by: Hao, Jianming
Published: (2013)

R-Smad 2 activation in infarcted rat heart : crosstalk between angiotensin II and TGF-[beta]1
by: Hao, Jianming
Published: (2013)

The role of epithelial-fibroblast communication in asthma and chronic obstructive pulmonary disease
by: Osei, Emmanuel Twumasi
Published: (2017)

Pulmonary Hypertension in Parenchymal Lung Disease
by: Iraklis Tsangaris, et al.
Published: (2012-01-01)

A ROLE OF ANGIOTENSIN-CONVERTING ENZYME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE SUMMARY
by: N. D. Elshin, et al.
Published: (2017-09-01)

Angiotensin-converting enzyme I/D polymorphism in chronic obstructive pulmonary disease
by: Pabst S, et al.
Published: (2009-12-01)

The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
by: Matthew R Weir, et al.
Published: (2001-03-01)

Studying the Roles of Angiotensin Converting Enzyme II (ACE2) In the Pathogenesis of Early-Stage Chronic Obstructive Pulmonary Disease
by: Hung, Yi-Han, et al.
Published: (2014)

Pulmonary parenchymal involvement caused by Tropheryma whipplei
by: Zhang Wen Mei, et al.
Published: (2021-06-01)

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease
by: Burkes RM, et al.
Published: (2020-12-01)

Evaluation of beta-blockers for the treatment of asthma and chronic obstructive pulmonary disease
by: Short, Philip
Published: (2014)

Pulmonary hypertensive vasculopathy in parenchymal lung diseases and/or hypoxia
by: Maria Rosa Ghigna, et al.
Published: (2017-06-01)

Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease.
by: Hoeke A Baarsma, et al.
Published: (2011-01-01)

Crosstalk of cardiomyocytes and fibroblasts in co-cultures
by: J. Rother, et al.
Published: (2015-01-01)

YAP-regulated epithelial-fibroblast crosstalk
by: Khaliqdina, Shoheera
Published: (2016)

Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease
by: M. E. Statsenko, et al.
Published: (2008-12-01)

Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients
by: Hallgren Oskar, et al.
Published: (2012-08-01)

Genetic Polymorphism of Angiotensin-Converting Enzyme and Chronic Obstructive Pulmonary Disease Risk: An Updated Meta-Analysis
by: Sang Wook Kang, et al.
Published: (2016-01-01)

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese
by: Köster LS, et al.
Published: (2016-02-01)

Macrophage exosomes transfer angiotensin II type 1 receptor to lung fibroblasts mediating bleomycin-induced pulmonary fibrosis
by: Na-Na Sun, et al.
Published: (2021-09-01)

Asthma and chronic obstructive pulmonary disease overlap: asthmatic chronic obstructive pulmonary disease or chronic obstructive asthma?
by: Annelies Slats, et al.
Published: (2016-02-01)

Diagnostic utility of medical thoracoscopy in peripheral parenchymal pulmonary lesions
by: E. Hatata, et al.
Published: (2015-07-01)

Pulmonary Hamartomas: A Report of 13 Parenchymal and Endobronchial Cases
by: Gülbanu Horzum Ekinci, et al.
Published: (2015-08-01)

Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease.
by: Ellen Andresen, et al.
Published: (2011-01-01)

Characteristics of Beta-blocker Treatment in Cardiac Patients with Concomitant Chronic Obstructive Pulmonary Disease
by: Frigy Attila, et al.
Published: (2016-12-01)

Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts.
by: Jian Bai, et al.
Published: (2013-01-01)

Stimulation of collagen gel contraction by angiotensin II and III in cardiac fibroblasts
by: Paul Lijnen, et al.
Published: (2002-09-01)

Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors
by: Paul J Lijnen, et al.
Published: (2001-06-01)

Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases.
by: Diandian Li, et al.
Published: (2021-01-01)

Sonographic Renal Parenchymal Measurements for the Evaluation and Management of Ureteropelvic Junction Obstruction in Children
by: Jeremy C Kelley, et al.
Published: (2016-05-01)

Pulmonary parenchymal involvement: A rare manifestation of adult scrub typhus
by: Muhammed Thoyyib, et al.
Published: (2020-01-01)